We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $30B
1-Year Est. Return 76.99%
This Fund
S&P 500
This Quarter Est. Return
+43.51%
1 Year Est. Return
+76.99%
3 Year Est. Return
+326.24%
5 Year Est. Return
+435.69%
10 Year Est. Return
+2,724.6%
AUM
$30B
AUM Growth
+$7.24B
Cap. Flow
+$923M
Cap. Flow %
3.08%
Top 10 Hldgs %
54.41%
Holding
509
New
65
Increased
131
Reduced
225
Closed
84

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$982M
2
NVDA icon
NVIDIA
NVDA
+$276M
3
NVO
Novo Nordisk
NVO
+$211M
4
LITE icon
Lumentum
LITE
+$203M
5
AMD icon
Advanced Micro Devices
AMD
+$185M

Sector Composition

Rank Sector Weight
1 Technology 41.55%
2 Communication Services 18%
3 Industrials 12.18%
4 Consumer Discretionary 11.21%
5 Healthcare 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITGR icon
326
Integer Holdings
ITGR
$4.29B
$1.85M 0.01%
19,765
-114,126
-85% -$10.1M
TMDX icon
327
Transmedics
TMDX
$3.06B
$1.78M 0.01%
26,741
-3,264
-11% -$276K
BKR icon
328
Baker Hughes
BKR
$63.5B
$1.77M 0.01%
31,833
-5,240
-14% -$331K
PL icon
329
Planet Labs
PL
$6.48B
$1.69M 0.01%
50,992
-124,792
-71% -$4.61M
BBIO icon
330
BridgeBio Pharma
BBIO
$14.6B
$1.65M 0.01%
22,170
-105,049
-83% -$7.36M
ELF icon
331
e.l.f. Beauty
ELF
$6.16B
$1.65M 0.01%
22,289
-152,388
-87% -$9.26M
ROAD icon
332
Construction Partners
ROAD
$5.85B
$1.6M 0.01%
13,500
-126,106
-90% -$15M
TMO icon
333
Thermo Fisher Scientific
TMO
$223B
$1.59M 0.01%
+3,176
New +$1.52M
BCPC
334
Balchem Corp
BCPC
$5.44B
$1.55M 0.01%
9,187
-53
-0.6% -$8.8K
ANF icon
335
Abercrombie & Fitch
ANF
$6.73B
$1.54M 0.01%
17,115
-317
-2% -$26.9K
NAMS icon
336
NewAmsterdam Pharma
NAMS
$3.06B
$1.53M 0.01%
45,115
-9,080
-17% -$299K
MRNA icon
337
Moderna
MRNA
$56B
$1.5M 0.01%
+21,435
New +$1.11M
ORCL icon
338
Oracle
ORCL
$468B
$1.5M 0.01%
10,217
-13,473
-57% -$2.44M
VRTX icon
339
Vertex Pharmaceuticals
VRTX
$134B
$1.48M ﹤0.01%
2,972
+539
+22% +$239K
CORZ icon
340
Core Scientific
CORZ
$6.02B
$1.43M ﹤0.01%
55,977
-817
-1% -$19.2K
LHX icon
341
L3Harris
LHX
$47.6B
$1.36M ﹤0.01%
4,685
-2,301
-33% -$731K
XYZ
342
Block Inc
XYZ
$48.1B
$1.36M ﹤0.01%
17,885
-2,443
-12% -$172K
LEGN icon
343
Legend Biotech
LEGN
$3.99B
$1.35M ﹤0.01%
+46,856
New +$1.26M
TJX icon
344
TJX Companies
TJX
$142B
$1.34M ﹤0.01%
8,816
-3,206
-27% -$507K
ENSG icon
345
The Ensign Group
ENSG
$9.94B
$1.33M ﹤0.01%
8,320
-9,638
-54% -$1.7M
MAIR
346
Madison Air Solutions
MAIR
$13.1B
$1.32M ﹤0.01%
+33,736
New +$1.31M
MKTX icon
347
MarketAxess Holdings
MKTX
$5.75B
$1.29M ﹤0.01%
11,398
-196
-2% -$27.9K
MIAX
348
Miami International Holdings
MIAX
$4.31B
$1.29M ﹤0.01%
34,593
+4,989
+17% +$223K
ALAI icon
349
Alger AI Enablers & Adopters ETF
ALAI
$1.17B
$1.28M ﹤0.01%
28,104
RTX icon
350
RTX Corp
RTX
$268B
$1.28M ﹤0.01%
6,747
-14,285
-68% -$2.62M

Similar funds

Fred Alger Management's Q2 2026 Portfolio in Review

As of Q2 2026, Fred Alger Management held 509 positions worth $30B, up 32% from $22.8B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Fred Alger Management deployed $923M of net new capital in Q2 2026, opening 65 new positions and adding to 131 existing holdings. Its largest new stake was SpaceX: 5,779,419 shares worth $987M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 39% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the largest reduction was Nebius Group N.V., an estimated $767M trimmed.

  • Fred Alger Management's largest Q2 2026 buy was SpaceX: 5,779,419 shares worth $987M.
  • Fred Alger Management added most to NVIDIA in Q2 2026, an estimated $276M increase.
  • Fred Alger Management's biggest Q2 2026 reduction was Nebius Group N.V., cutting an estimated $767M.
  • Fred Alger Management fully exited Palantir in Q2 2026, selling an estimated $95.2M.
  • Fred Alger Management's ten largest holdings make up 54% of its $30B portfolio in Q2 2026.
  • Fred Alger Management opened 65 new positions and closed 84 in Q2 2026.
  • Fred Alger Management's portfolio value rose 32% quarter-over-quarter to $30B.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.